Yair Nechmad - 16 Mar 2026 Form 3 Insider Report for Nayax Ltd. (NYAX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
16 Mar 2026, 11:54:48 UTC
Next SEC filing
27 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Yair Nechmad by: Oppenheimer Israel, as Attorney-in-fact

Key filing fact

Yair Nechmad filed Form 3 for Nayax Ltd. (NYAX) on 16 Mar 2026.

Key facts

  • This page summarizes Yair Nechmad's Form 3 filing for Nayax Ltd. (NYAX).
  • 0 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 16 Mar 2026, 11:54.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001999370 Primary reporting owner

Nechmad Yair

Relationship
CEO and Co Founder & Chairman
Address
C/O NAYAX LTD., 3 ARIK EINSTEIN, HERZLIYA, ISRAEL
Signature
Yair Nechmad by: Oppenheimer Israel, as Attorney-in-fact
Signature date
16 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NYAX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,406,075
Date
16 Mar 2026
Ownership
Held by Yair Nechmad Ltd.
Footnotes
F1
NYAX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,059,930
Date
16 Mar 2026
Ownership
Direct
Footnotes
F2
NYAX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
33,512
Date
16 Mar 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NYAX holding Derivative

Warrants (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
16 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
286,135
Exercise price
$56.90
Footnotes
F4, F5
NYAX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
16 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
75,000
Exercise price
$33.71
Footnotes
F6, F7
NYAX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
16 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
75,000
Exercise price
$33.71
Footnotes
F8, F9
NYAX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
16 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
70,000
Exercise price
$33.71
Footnotes
F10, F11
NYAX holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
16 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
15,605
Exercise price
$33.71
Footnotes
F12, F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

The shares were originally acquired as Founder Shares

Footnote F2

The shares were originally acquired as Founder Shares

Footnote F3

The Shares reported herein were purchased in the open market

Footnote F4

The reported securities represent Series 1 Warrants issued by the Company in connection with its 2025 offering of Series A Notes and Warrants. The Warrants are listed for trading on the Tel Aviv Stock Exchange

Footnote F5

Each Warrant is exercisable for one Ordinary Share at an exercise price of NIS 177.80, subject to adjustments based on changes in the NIS-to-USD exchange rate.

Footnote F6

The Stock Options are Fully vested and immediately exercisable

Footnote F7

The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.

Footnote F8

The Stock Options are Fully vested and immediately exercisable

Footnote F9

The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.

Footnote F10

The Stock Options are Fully vested and immediately exercisable

Footnote F11

The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.

Footnote F12

The Stock Options are Fully vested and immediately exercisable

Footnote F13

The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.

SEC remarks

This Form 3 is being filed to report the Reporting Persons beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .